Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
polylactic acid
- Development stage
- Unknown
- Lead developer
- SurModics
- Modality
- Small Molecules, Biodegradable Polymers → Polymer-based Nanoparticles → Nanoparticles → Drug Delivery Systems
- Administration
- Subcutaneous, Intradermal, Implant, Topical
01
Overview
Polylactic acid (PLA) is a biodegradable and biocompatible aliphatic polyester derived from renewable resources such as corn starch or sugarcane. It is widely used in the medical field for applications including absorbable implants (e.g., fixation rods, plates, pins, screws), sutures, tissue engineering scaffolds, wound covers/membranes, and as a polymeric carrier in drug delivery systems[3][5][6][7]. In dermatology and aesthetics—specifically as poly-L-lactic acid (PLLA)—it is used to restore facial volume loss (lipoatrophy) and correct wrinkles by stimulating collagen production through a local foreign body reaction[2][4]. PLA degrades into lactic acid within the body over months to years depending on formulation; its degradation products are metabolized naturally. Its immunologically inert profile reduces risk of chronic inflammation or adverse reactions[4][5].
- Brand names
- SculptraSculptra AestheticNew-Fill
- Other names
- poly-L-lactic acidpoly-D,L-lactic acidpoly(lactide)polylactide
02
Targets
COL1 (Collagen type I)
Beyond the preview
Go deeper on polylactic acid.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on polylactic acid.